Trials / Terminated
TerminatedNCT02273856
Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Astellas Pharma International B.V. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to document the pharmacological treatment strategies used in treatment naïve and previously treated relapsed/refractory iNHL/CLL patients in the Middle East and North African (MENA) region. This study will also record encountered tumor subtype and stage and the instituted pharmacological treatments, as well as assess the clinical outcomes of treatments.
Detailed description
Patients will be followed up to 30 months.
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2014-10-24
- Last updated
- 2016-06-21
Locations
8 sites across 7 countries: Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
Source: ClinicalTrials.gov record NCT02273856. Inclusion in this directory is not an endorsement.